- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 inhibitor
Total 105479 results
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Agenus Inc.Withdrawn
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular CarcinomaChina
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingCervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditionsCanada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
-
Gilead SciencesNimbus ApolloCompletedPD Effects of GS-0976 (NDI-010976) on Fractional DNLUnited States
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Henan Cancer HospitalRecruitingClassical Hodgkin LymphomaChina
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingUterine Cervical NeoplasmsCanada, United States, Australia, Austria, Belgium, Brazil, Chile, China, Colombia, Czechia, France, Germany, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Norway, Peru, Russian Federation, Spain, Sweden, ... and more
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
AnaptysBio, Inc.Recruiting
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsKorea, Republic of, United States, Spain, Taiwan, Turkey, Greece, Canada, Croatia, Serbia, Mexico, Cyprus, Georgia
-
Hunan Cancer HospitalRecruitingChemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic DisorderChina
-
Peking University Third HospitalUnknown
-
University Hospital, LilleINSERM U1189 ONCOTHAIRecruitingMalignant Pleural Mesothelioma | Mesotheliomas PleuralFrance
-
Shi MingSuspended
-
Peking Union Medical College HospitalRecruitingAnlotinib | Anti-PD-1 Antibody | Advanced Pancreatic CancerChina
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
University of PadovaDepartment of Ophthalmology, Conegliano Hospital, Treviso, ItalyUnknownNeovascular Age-Related Macular DegenerationItaly
-
Shanghai Ninth People's Hospital Affiliated to...Fudan University; First Affiliated Hospital of Fujian Medical University; Tianjin... and other collaboratorsRecruitingHead and Neck Squamous Cell CarcinomaChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Fujian Cancer HospitalNot yet recruitingLung Adenocarcinoma | PD-1 Inhibitor | Stage IV Non-small Cell Lung Cancer | VEGF
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Stereotactic Body Radiotherapy | Low Dose RadiotherapyChina
-
The First Hospital of Jilin UniversityRecruiting
-
Fujian Cancer HospitalSuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingEsophageal Neoplasms | Esophageal Squamous Cell CarcinomaChina
-
Sun Yat-sen UniversityGuangzhou Gloria Biosciences Co., Ltd.RecruitingClassical Hodgkin LymphomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Fudan UniversityZhejiang Cancer Hospital; Xijing Hospital; Shanghai Zhongshan Hospital; Tongji...Recruiting
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
National Cancer Institute (NCI)Recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Henlix, IncUnknown
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Merck Sharp & Dohme LLCCompleted
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsRecruitingOncology | NSCLC Stage IV | NSCLC, Stage IIINorway
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Hangzhou Cancer HospitalAnhui Kedgene Biotechnology Co.,LtdCompleted
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark